-
Product Insights
Seasonal Influenza - Drugs In Development, 2024
Empower your strategies with our Seasonal Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Seasonal influenza, commonly referred to as "the flu", is a contagious respiratory illness caused by influenza viruses. It typically occurs in outbreaks during the fall and winter months, peaking between December and February in the Northern Hemisphere. The flu can cause mild to severe illness and, in some cases, can lead to hospitalization or even death, especially among vulnerable populations. Symptoms of...
-
Product Insights
Middle East Respiratory Syndrome (MERS) - Drugs In Development, 2024
Empower your strategies with our Middle East Respiratory Syndrome (MERS) – Drugs In Development, 2024 report and make more profitable business decisions. Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting, and diarrhea. Pneumonia is common, and organs damage can occur to the kidneys or other organs. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The...
-
Product Insights
Candidiasis - Drugs In Development, 2024
Empower your strategies with our Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin; the folds of the buttocks; between...
-
Product Insights
Cytomegalovirus (HHV-5) Infections - Drugs In Development, 2024
Empower your strategies with our Cytomegalovirus (HHV-5) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Cytomegalovirus (CMV) is virus in the herpes family, also called HHV-5. CMV is spread through saliva or urine. Symptoms include fever, pneumonia, weight loss, and hearing, neurological, and developmental problems. The predisposing factors are direct contact with an infected surface or individual, weakened immune system, and congenital factors. It may be diagnosed by blood or urine tests. The condition may be...
-
Product Insights
Escherichia coli Infections - Drugs In Development, 2024
Empower your strategies with our Escherichia coli Infections – Drugs In Development, 2024 report and make more profitable business decisions. Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. E. coli infections are caused by coming into contact with the feces of humans or animals, or eating or drinking contaminated food or beverage. Symptoms include diarrhea, which may range from mild and watery to severe and bloody; abdominal cramping; pain or tenderness; nausea; and vomiting....
-
Product Insights
Klebsiella pneumoniae Infections - Drugs In Development, 2024
Empower your strategies with our Klebsiella pneumoniae Infections – Drugs In Development, 2024 report and make more profitable business decisions. Klebsiella pneumoniae is a Gram-negative bacteria. A Klebsiella pneumoniae infection is caused when the organism is able to enter the lungs, and is very common in patients with underlying diseases like diabetes, chronic lung disease, and alcoholism. It is mostly a nosocomial infection that occurs in hospitalized patients with weakened immune systems. Symptoms include necrosis, inflammation, hemorrhage, chills, dizziness, high fever,...
-
Product Insights
Rabies - Drugs In Development, 2024
Empower your strategies with our Rabies – Drugs In Development, 2024 report and make more profitable business decisions. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, difficulty swallowing, excitability, fever, and convulsions. The predisposing factors include exposure to wildlife and exposure to pets that are not vaccinated. The Rabies drugs in...
-
Product Insights
Tetanus - Drugs In Development, 2024
Empower your strategies with our Tetanus – Drugs In Development, 2024 report and make more profitable business decisions. Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever, sweating, elevated blood pressure, and rapid heart rate. The predisposing factors include burns, surgical wounds, ear infections, swelling around the injury, and infected foot ulcers. Treatment includes antibiotics, sedatives, and beta blockers. The Tetanus drugs...
-
Product Insights
Trypanosomiasis - Drugs In Development, 2024
Empower your strategies with our Trypanosomiasis – Drugs In Development, 2024 report and make more profitable business decisions. Trypanosomiasis, also known as sleeping sickness in humans and nagana in animals, is a parasitic disease caused by protozoan parasites of the genus Trypanosoma. There are two main forms of the disease, each caused by different species of Trypanosoma. African trypanosomiasis (sleeping sickness) is transmitted by tsetse flies and is predominantly found in sub-Saharan Africa. It is caused by two subspecies of the...
-
Product Insights
Influenza A Virus, H3N2 Subtype Infections - Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H3N2 infections are caused by variant H3N2 virus, which is a strain of influenza. Symptoms include cough, sore throat, runny or stuffy nose, chills, nausea, vomiting, and/or diarrhea. Risk factors include age and chronic medical conditions like asthma, diabetes, heart disease, weakened immune systems, and neurological or neurodevelopment conditions. Treatment includes antiviral medications and antibiotics. The Influenza A...